期刊文献+

重组人β防御素3在大肠杆菌中的表达和活性分析 被引量:14

Expression of Recombinant Human β-Defensin 3 in E.coli and Its Antimicrobial Activity Analysis
下载PDF
导出
摘要 Human β-defensin 3(hBD-3) is a short polypeptide with a wide range of antimicrobial activity,which was purified from human lesional psoriatic scales in 2001.To obtain high level expression in E.coli of β-defensin 3,four pairs of oligonucleotide with cosmic site were synthesised using E.coli biased codons according to the amino acid sequence of β-defensin 3, connected and amplified by PCR. The PCR product encoding human β-defensin 3 was cloned into pET30a vector.The recombinant vector was transformed into E.coli BL21(DE3)PlysS and the expression was induced by IPTG. The recombinant fusion protein was analyzed by SDS-PAGE and purified by affinity column. The mass of the fusion protein consisted of 30.9% in total bacteria proteins. The recombinant fusion protein was digested by enterokinase, resulting in the recombinant hBD-3. Antimicrobial activity analysis showed that both recombinant hBD-3 fusion protein and recombinant hBD-3 had similar potency as the native protein in suppressing growth of both gram positive bacteria S.aureus and gram negative one E.coli in a dose dependent manner. Human β-defensin 3 ( hBD3 ) is a short polypeptide with a wide range of antimicrobial activity, which was purified from human lesional psoriatic scales in 2001. To obtain high level expression in E. coli of β- defensin 3, four pairs of oligonucleotide with cosmic site were synthesised using E. coli biased codons according to the amino acid sequence of β-defensin 3, connected and amplified by PCR. The PCR product encoding human β-defensin 3 was cloned into pET30a vector. The recombinant vector was transformed into E. coli BL21 (DE3) PlysS and the expression was induced by IPTG. The recombinant fusion protein was analyzed by SDSPAGE and purified by affinity column. The mass of the fusion protein consisted of 30.9% in total bacteria proteins. The recombinant fusion protein was digested by enterokinase, resulting in the recombinant hBD3. Antimicrobial activity analysis showed that both recombinant hBD3 fusion protein and recombinant hBD3 had similar potency as the native protein in suppressing growth of both gram positive bacteria S. aureus and gram negative one E. coli in a dose dependent manner.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2005年第5期705-708,共4页 Chinese Journal of Biochemistry and Molecular Biology
基金 浙江省自然科学基金资助项目(No.Y204348 No.300024)~~
关键词 人防御素 重组人 活性分析 大肠杆菌 抗肿瘤作用 广谱高效 抗菌活性 抗菌能力 工程菌株 高效表达 β-defensin 3, molecular cloning, recombinant expression, activity analysis
  • 相关文献

参考文献11

  • 1Hancock Robert E W. Cationic peptides: effectors in innate immunityand novel antimicrobials. Lancet Infect Dis, 2001,11( 1 ): 156 ~ 164.
  • 2Periathamby A R, Andrew R D. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol Lett, 2002, 206: 9~ 18.
  • 3Ganz T, Selsted M E, Szklarek D, Harwig S S, Daher K, Bainton D F, Lehrer R I. Defensins, Natural peptide antibiotics of human neutrophils. J Clin Invest, 1985,76(4): 1427 ~ 1435.
  • 4Bensch K W, Raida M, Magert H J. hBD-1 :a novel beta-defensin from human plasma. FEBS Lett, 1995,368: 331.
  • 5Harder J, Bartels J. Christophers E, Schroder J M. A peptide antibiotic from human skin. Nature, 1997,387: 861.
  • 6Harder J, Bartels J. Christophers E, Schroder J M. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem, 2001, 276(8): 5707~5713.
  • 7Garcia J R, Krause A, Schulz S, Rodriguez-Jimenez F J, Kluver E, Adermann K, Forssmann U, Frimpong-Boateng A Bals R, Forssmann WG. Human β-defensin-4: a novel inducible peptide with a special salt sensitive spectrum of antimicrobial activity. FASEB J, 2001,15:1819 ~ 1821.
  • 8Andersson S G E, Kurland C G. Coden preferences in free-living microorganisms. Microbiol Rev, 1990(6): 198 ~ 210.
  • 9Sambrook J, Russell D W. Molecular Cloning: A Laboratory Manual, 3rd ed.New York:Cold Spring Harbor Laboratory Press, 2001.
  • 10陈姗,何凤田,董燕麟,李蓉芬,高会广,陈敏,彭家和.人β防御素3融合蛋白在大肠杆菌中的表达、纯化与活性分析[J].生物工程学报,2004,20(4):490-495. 被引量:20

二级参考文献26

  • 1Francois J Picard,Michel G.Bergeron molecular theranostics in infectious diseases is an emerging concept in which molecular biology tools are used to provide rapid and accurate diagnostic assays.Drug Discovery Today,2002,7:1092-1101
  • 2Steven J Projan.Although the need for new antibacterial therapies and strategies is greater than it has been in a quarter of a century,little progress has been observed in the development of new antibacterial agents.Current Opinion in Pharmacology,2002,2:
  • 3Robert E W,Hancock Daniel S.Chapple.Peptide antibiotics.Antimicrobial agents and chemotherapy,1999,43:1317-1323
  • 4Allington D R,Rivey M P.Quinupristin/ dalfopristin:a therapeutic review.Clin-Ther,2001,23:24-44
  • 5Boman-HG.Gene-encoded peptide antibiotics and the concept of innate immunity:an update review.Scand-J-Immunol,1998,48:15-25
  • 6Charles A.Janeway Jr.How the immune system protects the host from infection.Microbes and Infection,2001,3:1167-1171
  • 7Robert Bals.Epithelial antimicrobial peptides in host defense against infection.Respir Res,2000,1:141-150
  • 8Schroder JM.Epithelial antimicrobial peptides:innate local host response elements.Cell-Mol-Life-Sci,1999,56:32-46
  • 9Pardi A,Zhang XL,Selsted ME et al.NMR studies of defensin antimicrobial peptides:Three-dimensional structures of rabbit NP-2 and human neutrophil-1.Biochemistry,1992,31:11357-11364
  • 10Weinberg A,Krisanaprokornkit S,Dale B A.Epithelial antimicrobial peptides:Review and significance for oral applications.Crit Rev Oral Biol Med,1996,9:399-414

共引文献19

同被引文献144

引证文献14

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部